semaglutide prostate cancer Prostate Cancer Center of Excellence Treatments Expanding for Metastatic Prostate

PlexusDx compounded medications from licensed 503A pharmacies, paired with genetic and biomarker insights, enable a truly precision-guided conversation with your healthcare team about safety and efficacy for your specific situation

Specifically, reduced GLP-1 was associated with altered expression of the pro-inflammatory macrophage marker CD86

Our staff is dedicated to providing empathetic and personalized attention, taking the time to understand your unique needs and concerns

Your provider may also assess whether your medication dose is appropriate, or whether a temporary dose adjustment could help your body adapt while you stabilize your nutrition